Cite
Onset of efficacy and adverse events during Cenobamate titration period
MLA
Bernhard J. Steinhoff, et al. Onset of Efficacy and Adverse Events during Cenobamate Titration Period. Sept. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f8b5ce9778ed19d59302309a47e50948&authtype=sso&custid=ns315887.
APA
Bernhard J. Steinhoff, Elinor Ben‐Menachem, Christian Brandt, Irene García Morales, William E. Rosenfeld, Estevo Santamarina, & José M. Serratosa. (2022). Onset of efficacy and adverse events during Cenobamate titration period.
Chicago
Bernhard J. Steinhoff, Elinor Ben‐Menachem, Christian Brandt, Irene García Morales, William E. Rosenfeld, Estevo Santamarina, and José M. Serratosa. 2022. “Onset of Efficacy and Adverse Events during Cenobamate Titration Period,” September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f8b5ce9778ed19d59302309a47e50948&authtype=sso&custid=ns315887.